Filling the information void: Using public registries as a tool in nanotechnologies regulation

Journal of Bioethical Inquiry

Volumn 6, Issue 1, 2009, Pages 25-36

  Bowman, Diana M ^a   Ludlow, Karinne ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Nanotechnologies; Public health and safety; Registries; Regulation; Transparency

Indexed keywords

EID: 60449100831     PISSN: 11767529     EISSN: 18724353     Source Type: Journal    
DOI: 10.1007/s11673-009-9134-9     Document Type: Article

References (41)

1. BASF. 2004. Code of conduct for nanotechnology. Ludwigshafen: BASF.
2. BASF. 2006. In dialogue: Nanotechnology at BASF. Ludwigshafen: BASF.
3. Coalition of Non-Governmental Organizations. 2007. Principles for the oversight of nanotechnologies and nanomaterials, 31 July. http://www.foeeurope. org/activities/nanotechnology/Documents/Principles-Oversight-Nano.pdf (accessed October 7, 2007).
4. J. Couzin 2004 Drug research: legislators propose a registry to track clinical trials from start to finish Science 305 5691 1695
5. Davies, S. 2008. Letter: Nano-enabled choice. The Guardian, 29 March. http://www.guardian.co.uk/science/2008/mar/29/nanotechnology (accessed June 5, 2008).
6. C. DeAngelis J.M. Drazen F.A. Frizelle C. Haug 2004 Editorial: clinical statement registration: a statement from the international committee of medical journal editors Canadian Medical Association Journal 171 6 606 607
7. C. DeAngelis J.M. Drazen F.A. Frizelle C. Haug 2004 Is this clinical trial fully registered? a statement from the international committee of medical journal editors Canadian Medical Association Journal 172 13 1700 1702
8. Denison, R. 2007. Statement of Richard A. Denison, Ph.D., Senior Scientist USEPA's Public Meeting on the Development of a Voluntary Nanoscale Materials Stewardship Program, 2 August. Washington DC: Environmental Defense.
9. Department of Environment, Food and Rural Affairs. 2006a. UK voluntary reporting scheme for engineered nanoscale materials. London: Defra.
10. Department of Environment, Food and Rural Affairs. 2006b. Consultation on a proposed voluntary reporting scheme for engineered nanoscale materials-Consultation questions. London: Defra.
11. Department of Environment, Food and Rural Affairs. 2008. The UK voluntary reporting scheme for engineered nanoscale materials: Seventh quarterly report, August. London: Defra.
12. Environmental Defense. 2008. Press Release: EPA nanotechnology voluntary program risks becoming a "black hole", 28 July. New York: Environmental Defense.
13. Environmental Defense and DuPont. 2007. Nano risk framework. New York: EDF.
14. Environmental Protection Agency 2008 Notice: nanoscale materials stewardship program Federal Register 73 18 4861 4866
15. Fleming, N. 2006. Women buying creams made of tiny particles "used as guinea pigs". The Daily Telegraph. London, 5 May, p.6.
16. Gold, J.L., and D.M. Studdert. 2005. Clinical trials registries: a reform that is past due. The Journal of Law, Medicine & Ethics 811-820. (Winter). doi: 10.1111/j.1748-720X.2005.tb00547.x.
17. A.M. Gulmezoglu T. Pang R. Horton K. Dickersin 2005 WHO facilitates international collaboration in setting standards for clinical trial registration The Lancet 365 28 May 1829 1831
18. C. Haug P.C. Gotzsche T.V. Schroeder 2005 Registries and registration of clinical trials The New England Journal of Medicine 353 26 2811 2812
19. Interessengemeinschaft Detailhandel Schweiz. 2008. Code of conduct for nanotechnologies. Geneva: Swiss Retailer's Association.
20. International Council on Nanotechnology. 2005. Nano coalition unveils environmental, health and safety database. http://www.icon.rice.edu/ (accessed August 19, 2006).
21. International Council on Nanotechnology. 2008a. Working groups: Knowledge base team. http://icon.rice.edu/projects.cfm?doc-id=4389 (accessed October 30, 2008).
22. International Council on Nanotechnology. 2008b. EHS Database, last updated 23 October. http://cohesion.rice.edu/centersandinst/icon/research.cfm (accessed October 30, 2008).
23. D. Kelsall 2006 Stand and declare: Opportunity and challenge of clinical trial registration Canadian Family Physician 52 1189 1190
24. C. Laine R. Horton C.D. DeAngelis J.M. Drazen 2007 Clinical trial registration-looking back and moving ahead The New England Journal of Medicine 356 26 2734 2735
25. T. Lemmens R.A. Rouchard 2007 Mandatory clinical trial registration: rebuilding public trust in medical research Global Forum Update on Research for Health 4 40 46
26. Martinez, B. 2004. Glaxo settles New York suit over unpublished clinical data. The Wall Street Journal 27 August: B3.
27. A.D. Maynard R. Aitken T. Butz V.L. Colvin 2006 Safe handling of nanotechnology Nature 444 267 269
28. C. Medina M.J. Santos-Martinez A. Radomski O.I. Corrigan M.S. Radomski 2007 Review: nanoparticles: pharmacological and toxicological significance British Journal of Pharmacology 150 552 558
29. G. Oberdörster V. Stone K. Donaldson 2007 Toxicology of nanoparticles: a historical perspective Nanotoxicology 1 1 2 25
30. Organisation for Economic Co-operation and Development. 2008. Nanotechnologies at the OECD. Paris: OECD.
31. C.A. Poland R. Duffin I. Kinlock A.D. Maynard 2008 Carbon nanotubes introduced into the abdominal cavity of mice show asbestos like pathogenicity in a pilot study Nature Nanotechnology 3 423 428
32. Soil Association. 2006. A proposed voluntary reporting scheme for engineered nanoscale materials. Soil Association response to Defra consultation, July. https://www.soilassociation.org/web/sa/saweb.nsf/ b0062cf005bc02c180256a6b003d987f/9e47591b80454944802571b8003c5745? OpenDocument&Highlight=2 (accessed May 5, 2007).
33. Standing Committee on State Development. 2008. Nanotechnology in New South Wales. Sydney: NSW Legislative Council.
34. Stark, D. 2007. Defra nanotechnology stakeholder meetings, 14 February. http://www.euronanotrade.com/index.php?option=content&task=view&id= 557&Itemid=83# (accessed March 6, 2007).
35. R. Steinbrook 2004 Registration of clinical trials-voluntary or mandatory? The New England Journal of Medicine 351 18 1820 1822
36. Stuart, C. 2005. Making labor safety a priority and a profit. Small Times November/December: 32-33.
37. US National Institute of Health. 2008. About ClinicalTrials.gov. http://www.clinicaltrial.gov/ct2/info/about (accessed November 2, 2008).
38. Woolas, P. 2008. From the Minister for the Environment: UK voluntary reporting scheme for engineered nanoscale materials, 20 March. London: Defra.
39. World Health Organization. 2008a. About the WHO ICTPR. http://www.who.ntictrp/about (accessed November 2, 2008).
40. World Health Organization. 2008b. International Clinical Trials Registry Platform (ICTRP): Unique identification. http://www.who.int/ictrp/utrn/en/ (accessed November 2, 2008).
41. D.A. Zarin T. Tse N. Ide 2005 Trial registration at ClinicalTrials.gov between May and October 2005 The New England Journal of Medicine 353 26 2779 2787